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Abstract
Golden retriever muscular dystrophy (GRMD) is a well-established model of Duchenne muscular
dystrophy. The value of this model would be greatly enhanced with practical tools to monitor
progression of respiratory dysfunction during treatment trials. Arterial blood gas analysis, tidal
breathing spirometry, and respiratory inductance plethysmography (RIP) were performed to
determine if quantifiable abnormalities could be identified in unsedated, untrained, GRMD dogs.
Results from 11 dogs with a mild phenotype of GRMD and 11 age-matched carriers were
compared. Arterial blood gas analysis was successfully performed in all dogs, spirometry in 21 of
22 (95%) dogs, and RIP in 18 of 20 (90%) dogs. Partial pressure of carbon dioxide and
bicarbonate concentration were higher in GRMD dogs. Tidal breathing peak expiratory flows were
markedly higher in GRMD dogs. Abnormal abdominal motion was present in 7 of 10 (70%)
GRMD dogs. Each technique provided objective, quantifiable measures that will be useful for
monitoring respiratory function in GRMD dogs during clinical trials while avoiding the influence
of sedation on results. Increased expiratory flows and the pattern of abdominal breathing are novel
findings, not reported in people with Duchenne muscular dystrophy, and might be a consequence
of hyperinflation.
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Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of people,
with incidence per 100,000 male live births ranging from 13.0 – 28.2.[1,2] It is an X-linked,
recessive disease caused by a mutation in the gene encoding dystrophin. The disease is
ultimately fatal, with respiratory failure accounting for up to 80% of deaths.[3,4] Respiratory
failure results from progressive ventilatory compromise, often complicated by bronchial
infection or pneumonia.[5] Breathing is impaired by weakness of the respiratory muscles
and decreased chest wall and lung compliance.[4-7] Sleep-disordered breathing, upper
airway obstruction, and other factors might contribute to nocturnal hypoventilation.[4,8,9]
Macroglossia, reported in one third or more of patients, contributes to upper airway
obstruction.[5,10] Airway clearance is impacted by decreased effectiveness of cough.[11]
Pulmonary function tests can be used to characterize abnormalities in patients with DMD,
monitor progression of disease, and guide the institution of interventional strategies.
[3,4,7,8,10,12-14] For instance, daytime hypercapnia is detected late in the course of
disease, while nocturnal hypercapnia occurs earlier and can be an indication for non-
invasive intermittent positive pressure ventilation.[4,8,9] Forced vital capacity (FVC),
forced expiratory volume in 1 second (FEV1), and peak expiratory flow (PEF) decrease with
progression of disease when reported as a percentage of predicted value.[3,4,7,13-16]
Golden retriever muscular dystrophy (GRMD) is the closest genotypic and phenotypic
animal model of DMD.[17-21] Progressive skeletal muscle atrophy, contracture, abnormal
gait, and exercise intolerance occur, with signs beginning shortly after birth.[22-25] As in
people, death may occur due to respiratory failure.[19,23,26,27] Some puppies develop a so-
called fulminant form of the disease that can lead to death in the neonatal period.[19]
Valentine, et al. speculated that death could occur due to early, severe diaphragmatic
involvement.[19] In our experience, these severely affected pups often have dramatic
respiratory distress, in keeping with respiratory muscle disease, potentially compounded by
delayed pulmonary development (pulmonary hypoplasia), akin to that seen with congenital
diaphragmatic hernia.[28](Kornegay JN, McLean S, unpublished observations, 2011) As
GRMD dogs mature, they continue to have respiratory difficulty, as evidenced most notably
by increased respiratory rate and abdominal breathing.[19] Dogs exhibit macroglossia,
drooling, and difficulty eating.[22-25] Pharyngeal and esophageal muscles may be affected.
[22-25,29]. Associated difficulty in swallowing and regurgitation can predispose GRMD
dogs to aspiration, with 60% reportedly developing pneumonia in one study.[27] Evaluation
of the pulmonary system in GRMD dogs has been limited to clinical and radiographic
assessment. Radiographic abnormalities include diaphragmatic flattening and undulations,
hyperinflation of the lung, and hiatal hernia.[29,30]
The value of GRMD as a model for DMD would be greatly enhanced with practical tools to
monitor progression of respiratory dysfunction during treatment trials. In our study, arterial
blood gas analysis, tidal breathing spirometry, and respiratory inductance plethysmography
(RIP) were performed to determine if quantifiable abnormalities could be identified in
unsedated, untrained, GRMD dogs. We hypothesized that GRMD dogs would have:
increased partial pressure of arterial CO2 (PaCO2) and decreased tidal volume (TV), as a
result of hypoventilation; decreased peak tidal inspiratory flow (PTIF) and decreased
expiratory time relative to inspiratory time (TimeExp:TimeInsp), as a result of upper airway
obstruction and relatively prolonged inspiration; and asynchronous chest and abdominal
movements, as a result of diaphragm weakness.
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2. Materials and Methods
2.1. Animals and instrumentation
Golden retriever-cross dogs from a GRMD colony were studied. Eleven dogs were affected
with GRMD and eleven dogs were phenotypically normal, heterozygote carriers (control
dogs). Dogs from both groups were used in breeding. Newborn GRMD dogs were identified
based on elevation of serum creatine kinase (CK) and subsequently developed characteristic
clinical signs. In cases where CK results were ambiguous, genotype was confirmed by
polymerase chain reaction (PCR) methodology as previously described.[31] Dogs were used
and cared for according to principles outlined in the National Institutes of Health Guide for
the Care and Use of Laboratory Animals. Experimental procedures were approved by the
Institutional Animal Care and Use Committee of the University of North Carolina.
Pairs of dogs between groups were age-matched within 2.5 months, and were from the same
litter when possible. No dog had a history of illness in the month prior to study. Immediately
prior to data collection, all dogs had a general physical examination including thoracic
auscultation. No dogs had abnormal lung sounds on auscultation nor increased respiratory
effort. Two GRMD dogs were noted to have intermittent stertorous breathing. One affected
dog had a heart murmur on auscultation. One of the control dogs had mildly elevated body
temperature initially; however, it was normal on repeat measurement.
Dogs with GRMD had postural changes consistent with a mild disease phenotype.[23,32]
All affected dogs had some degree of macroglossia. In six of the dogs, the macroglossia was
moderate to severe, with some of these dogs unable to fully close their mouth due to the size
of their tongue.
Dogs were not trained to the equipment or procedures. All data collection was performed
with the dog on an examination table in a quiet room without distractions. Dogs were
instrumented for RIP with a commercially available, telemetric, jacketed system (Data
Sciences International, St. Paul, MN) prior to beginning any data collection. Rib cage and
abdominal elastic RIP bands were incorporated within a spandex shirt, and were placed so
that 2 fingers could pass, with minimal pressure, between the bands and the body wall to
avoid restriction of breathing. A loose fitting outer mesh jacket held wires and a telemetric
device, which transmitted data to the processing computer.
2.2. Arterial blood gas analysis
Arterial blood samples were collected from the dorsal pedal artery using syringes containing
dry lithium heparin (Vital Signs Colorado, Inc., Englewood, CO). Samples were
immediately analyzed using a bed-side instrument, with values adjusted for body
temperature by the device (VetScan i-STAT, Abaxis, Union City, CA). Values obtained
included: partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2),
acidity (pH), bicarbonate concentration (HCO3), carbon dioxide content (TCO2), and lactate
concentration. For dogs with a PaO2 <80 mmHg, a second specimen was obtained to
minimize the possibility of venous contamination of the initial specimen resulting in the low
PaO2. The specimen with the higher PaO2 value was used.
2.3. Tidal breathing spirometry
After blood collection, dogs were allowed to acclimate on an examination table for at least 5
minutes, until they maintained a stable, standing or sternal position, with minimal physical
restraint. A clear, rigid, plastic, anesthetic facemask with a rubber gasket (Surgivet, Smiths
Medical ASD, Inc., St. Paul, MN) was placed over the dog’s muzzle and secured via a strap
behind the ears. The same size facemask was used in all dogs and was sufficient to cover the
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commissures of the lips, while minimizing dead space. The mask was attached to a
pneumotachograph (Model 3700, Hans Rudolph, Inc., Shawnee, KS), which was connected
to a pressure transducer (DP45, Validyne, Northridge, CA). The signal was digitized, stored,
and analyzed using a commercial physiology software platform (Ponemah Physiology
Platform 4.90 – SP2, Data Sciences International, St. Paul, MN), with a sampling rate of 500
Hz. A capnometer (Welch Allyn, Inc., Skaneateles Falls, NY) was placed distal to the
pneumotachograph. The pneumotachograph was calibrated using an inline flow meter (TSI,
Shoreview, MN) prior to data collection from each dog. Data were collected for a minimum
of 4 minutes.
Throughout collection of spirometric data, end-tidal CO2 (etCO2) was monitored
continuously and respiratory rates were measured by visual assessment each minute. Values
for etCO2 were recorded for most dogs at 1, 2, 3, and 4 minutes. The mask was to be
removed if the dog became agitated or appeared distressed, or if either the etCO2 or
measured respiratory rate showed steadily increasing values. The mask was to be replaced as
soon as the dog appeared to relax and was breathing with ease.
Spirometry data were analyzed as has been previously reported.[33-38] For each dog, 8-10
tidal breaths representative of the predominant pattern were selected. Criteria for selection of
breaths included: lack of artifacts, such as resulting from panting, sniffing, cough, or
movement, on visual examination of the flow-time tracings; a difference of ≤5% between
inspiratory and expiratory volumes, to exclude breaths with evidence of leaking of air from
the mask; and, a respiratory frequency of ≤60 breaths per minute, to exclude panting.
Quantitative parameters included: respiratory rate (RR), expiratory time (TimeExp),
inspiratory time (TimeInsp), tidal volume (TV), minute volume (MV), peak tidal expiratory
flow (PTEF), peak tidal inspiratory flow (PTIF), tidal expiratory flow at 50%, 25% and
12.5% of TV (TEF50, TEF25, TEF12.5), and tidal inspiratory flow at 50% of TV (TIF50).
Tidal volume, PTEF and PTIF were also compared after adjusting for body weight (TV/kg,
PTEF/kg, and PTIF/kg). Ratios were determined for: expiratory versus inspiratory time and
flows (TimeExp:TimeInsp, PTEF:PTIF, TEF50:TIF50); inspiratory flows at different
volumes of the same breath (PTIF:TIF50); and expiratory flows at different volumes of the
same breath (PTEF:TEF50, PTEF:TEF25; PTEF:TEF12.5; TEF50:TEF25; TEF50:TEF12.5;
TEF25:TEF12.5). Flow-volume curves were subjectively described.
2.4 Respiratory inductance plethysmography
Immediately following spirometry, the facemask was removed and the dogs were allowed to
rest for 5 minutes. RIP data were then collected for 5 minutes without the facemask in place,
and an additional 5 minutes with the facemask placed over the muzzle as described for
spirometry. Voltage signals from the abdominal and rib cage bands were collected, stored,
and analyzed using a commercial physiology software platform (Ponemah Physiology
Platform 4.90 – SP2, Data Sciences International, St. Paul, MN). Signals were calibrated for
volume for each dog using qualitative diagnostic calibration (QDC) and a fixed volume.[39]
The median tidal volume obtained by spirometry for each dog was used for this volume
calibration, as the processor did not have the capability to concurrently collect spirometry
and RIP data. To obtain the best match of breathing mechanics during the periods of
spirometry and RIP data collection, the last 5 minutes of RIP data collected with the
facemask in place were used for statistical analysis. For each dog, at least 8 breaths
representative of the predominant pattern were selected. Quantitative parameters included:
RR, TimeExp, TimeInsp, TV, MV, PTEF, PTIF, TEF50, TIF50, and phase angle. Ratios
were determined for: TimeExp:TimeInsp, PTEF:PTIF, and TEF50:TIF50.
The relationship between rib cage and abdominal motion was examined quantitatively by
measurement of phase angle. Phase angle was calculated by the software program as 360
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times the time difference between peak chest and abdominal motion divided by the
respiratory cycle time and reported in degrees. Qualitative evaluation was done by the visual
comparison of the raw voltage output from the rib cage and abdomen bands over time and as
Konno-Mead plots. The raw signals were not standardized for gain or calibrated by volume.
Konno-Mead plots display output from the abdomen band on the x-axis and that from the rib
cage band on the y-axis, and typical patterns can be recognized.[40,41] In normal breathing,
the rib cage and abdomen expand and contract in synchrony and the Konno-Mead plot will
be a closed loop with a positive slope. In asynchronous breathing, the motion of the rib cage
does not occur at the same time as the abdomen and the resulting plot will be a more open
loop. In paradoxical breathing, the abdomen decreases in volume as the rib cage expands
and the abdomen expands as the rib cage decreases in volume. The resulting plot will have a
negative slope.
2.5 Statistical analysis
Statistical analyses were conducted with SigmaPlot software version 11.0.(Systat Software,
Inc, Chicago, IL). Coefficients of variation (one standard deviation as a percentage of the
mean) were calculated for spirometric data from each dog as an indication of consistency of
measurements between their representative breaths.[33] Student’s t-test or Mann-Whitney
rank sum test was used to compare data from GRMD and control dogs. Pearson product-
moment correlation or Spearman rank order was used to identify any relationship between
RR and PaCO2 and to compare parameters obtained by spirometry with those obtained by
RIP. P <0.05 was considered significant. For consistency, data are reported as median (25-/
75-percentiles).
3. Results
3.1. Subjects, respiratory rates and heart rates
The initial study group was comprised of 11 GRMD and 11 control dogs. Spirometric data
were inadequate for analysis from one of the eleven GRMD dogs. This dog maintained his
general body position throughout collection, but made frequent movements of his head.
During analysis of the tracings, eight representative breaths could not be identified based on
the defined criteria. As such, this dog and the age-matched control dog were removed from
all analysis, leaving 10 dogs in each of the 2 groups.
Eight of the remaining10 pairs of dogs were littermates. The median (25-/75- percentile) age
of GRMD dogs was 47.7 (17.0/55.4) months, and was purposefully similar to control dogs,
which had a median age of 47.5 (17.0/53.4) months. Nine of the 10 GRMD dogs were male,
and all control dogs were female. Dogs with GRMD weighed less (16.5 [15.3/18.9] kg) than
control dogs (20.3 [19.0/22.7] kg, P=0.001). On physical examination, GRMD dogs had a
lower respiratory rate (20 [16/24] breaths per minute) than control dogs (28 [24/36] breaths/
min, P= 0.027). In contrast, dogs with GRMD had a higher heart rate (131 [128/144] beats/
min) compared with control dogs (120 [108/136] beats/min), but statistical significance was
not reached (P=0.079).
3.2. Performance of procedures
Arterial blood specimens were obtained without difficulty from all 22 dogs. A single
puncture was required for successful specimen collection in 19 dogs. Based on our criteria to
collect a second specimen if the PaO2 was <80 mmHg, a second specimen was collected in
3 dogs.
Spirometry data were successfully collected from 21 of 22 dogs (95%). The majority of dogs
(n=19) were evaluated while sternal, with 2 GRMD dogs and 1 control dog preferring to
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stand. The facemask had to be removed from 5 of 22 dogs (22%) when the dogs either
would not remain in position with minimal restraint or showed signs of respiratory
difficulty. Of these 5 dogs, 3 had GRMD and 2 were control dogs. The mask was removed
once in 3 dogs, twice in 1 dog, and three times in 1 dog. The mask could be replaced within
approximately one to two minutes, and data collection continued. Mask removal was most
commonly associated with dog resistance to the mask or panting, which would preclude
quality data collection. Removal was only associated with apparent respiratory difficulty in
1 GRMD dog. None of the dogs were noted to have increased etCO2, indicating that the
instrumentation was not creating a large dead space. Analysis of recorded etCO2
measurements at 1 and 4 minutes of data collection failed to show any difference when
comparing: values at 1 minute and 4 minutes for each dog using paired t-test (P=0.529); or
the difference between the two values between GRMD dogs and controls (P=0.569).
Respiratory inductance plethysmography was successfully performed in 18 of 20 (90%)
dogs. There were insufficient breaths with a regular pattern to analyze due to movement
artifact in one GRMD and one control dog. These dogs were removed from analysis. In
another dog with GRMD, abnormal abdominal motion interfered with the analysis software
which made the derived data inaccurate. Data from this dog was excluded from numerical
comparisons, but not from qualitative assessment.
3.3. Arterial blood gas analysis
Dogs with GRMD had higher PaCO2 (median [25-/75- percentile], 38.8 [35.3/41.8] mmHg)
compared with control dogs (35.1 [31.9/36.2] mmHg; P=0.014 ). In addition, GRMD dogs
had higher HCO3 (23.6 [21.1/24.0] mEq/L; control dogs, 19.9 [18.4/21.1] mEq/L; P<0.001),
and TCO2 (25.0 [21.8/25.0] mEq/L; control dogs, 21.0 [19.0/22.3] mEq/L; P=0.001). No
differences were found for PaO2 (P=0.979), pH (P=0.762), or lactate concentration
(P=0.571). Correlation statistical analysis failed to identify a relationship between RR as
measured during physical examination or by spirometry, and PaCO2.
3.4. Tidal breathing spirometry
Results of tidal breathing spirometry are summarized in Table 1. Dogs with GRMD had
significantly higher peak tidal expiratory flow as measured directly (PTEF, P=0.002) and
when compared with peak tidal inspiratory flow (PTEF:PTIF, P<0.001). Tidal expiratory
flows at 50% of TV (TEF50) were also significantly elevated in the GRMD group
(P=0.002). Ratios of flow values early in expiration to values later in expiration were
elevated in GRMD dogs (PTEF:TEF25, P=0.002; PTEF:TEF12.5, P<0.001; TEF50:TEF25;
P<0.001; TEF50:TEF12.5, P<0.001; TEF25:TEF 12.5 P=0.002), with the exception of
PTEF:TEF50 (P=0.970).
Coefficients of variation for directly measured parameters (i.e. not including ratios) for each
dog ranged from 2-33%. Mean coefficients of variation from all dogs for each measured
parameter ranged from 7% for TV to 20% for EF12.5. Mean coefficients of variation from
all dogs were similar between groups for most measured parameters, with the mean value
more often lower for GRMD dogs than controls.
The increased expiratory flows and ratios were apparent in the predominant shapes of the
flow-volume loops as assessed subjectively. In 9 of 10 GRMD dogs, the expiratory phase of
the flow-volume loop was visibly greater than the inspiratory phase, and a pronounced peak
expiratory flow was often present (Figure 1).
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3.5 Respiratory inductance plethysmography
Good correlation was found between parameters measured by both spirometry and RIP,
which included TV, BPM, TimeExp, TimeInsp, PTIF, PTEF, TIF50, and TEF50 (P<0.001),
although absolute values differed between methods. Similar to spirometry, dogs with
GRMD had significantly greater PTEF (P=0.008), TEF50 (P<0.001), PTEF:PTIF (P=0.004)
and TEF50:TIF50 (P<0.001). Other parameters, including phase angle, were not different
between groups (Table 2).
Abnormal abdominal motion by qualitative analysis was present in 7 of 10 (70%) GRMD
dogs. Near synchronous motion of the rib cage and abdomen occurred during expansion of
the rib cage, but paradoxical abdominal motion occurred in early inspiration and/or late
expiration. This resulted in two abdominal peaks for each expansion of the rib cage. In
comparison to the expected abdominal peak during inspiration, the size of the abnormal
abdominal peak ranged from minimal to marked (Figure 2). In these dogs, the Konno-Mead
plots formed a “C” shape arising from the paradoxical motion at the beginning of inspiration
and end of expiration (Figure 2). The failure to identify a difference in phase angle between
the two groups of dogs is a result of the calculation method, which accounts only for the
relationship of peak rib cage expansion and predominant abdominal peak. No control dogs
exhibited this abnormal abdominal motion and Konno-Mead plots were roughly linear with
a positive slope. No obvious relationship could be seen between the degree of Konno-Mead
plot abnormality and age, body weight, CO2, TV, PEF, or PEF:PIF values.
Our primary purposes for collecting RIP data were to compare results with spirometry data
and to assess rib cage and abdominal motion. Due to the inability to collect spirometry and
RIP data simultaneously, we focused our quantitative assessment on RIP with a facemask in
place to have consistency of breaths. However, to investigate the unusual abdominal
breathing pattern further, we qualitatively examined the RIP data from the period when the
dogs were not wearing a facemask. The quality of these RIP tracings was generally poor as a
result of artifacts from body movement and panting. Better results would likely be obtained
if dogs were left alone in a kennel in a quiet room for prolonged periods of time. This is a
feasible future approach given the telemetric capabilities of the system. Despite the
limitation in the data collected without a facemask, 3 GRMD dogs and no control dogs had
detectable periods of paradoxical breathing (i.e. greater abnormal abdominal motion)
without a facemask in place (Figure 2).
4. Discussion
Respiratory function tests used in this study successfully identified abnormalities in dogs
with GRMD without sedation or training. Higher peak expiratory flows were documented by
spirometry and RIP. Abnormal abdominal motion was identified by RIP in the majority of
dogs. Moreover, relatively higher PaCO2 and HCO3 concentrations were found by arterial
blood gas analysis.
The median value of the PTEF in the GRMD dogs was over 80% greater than that of control
dogs, based on spirometry and RIP. Flow values as calculated from RIP measurements were
not identical to those measured by spirometry, but showed good correlation. Discrepancies
were expected because data were not collected simultaneously and different methodologies
were used.[42] Increased expiratory flows have not been reported in people with DMD as
measured with forced maneuvers. One plausible explanation for the increased peak tidal
expiratory flows in GRMD dogs is increased elastic recoil secondary to hyperinflation.
Hyperinflation is a common radiographic finding in GRMD dogs.[29,30] Purposeful
hyperinflation in healthy people causes increased forced peak expiratory flows,[43] and is a
technique used by people with DMD to improve effectiveness of cough through increased
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cough peak flows.[44] With hyperinflation due to lower airway obstruction, chest wall recoil
may be inwards, adding to lung recoil in driving tidal expiratory flow.[45] Such an effect
could be amplified in GRMD dogs because of replacement of intercostal muscles with
fibrous tissue.
The genesis of the hyperinflation in GRMD dogs is not known, and the study design did not
include evaluation for hyperinflation. Brummit, et al. hypothesized that hyperinflation might
be secondary to decreased diaphragmatic excursion due to pseudohypertrophy of the
diaphragm, leading to a compensatory change in intercostal musculature.[30] Another
possibility is that bronchial smooth muscle undergoes hyperplastic and/or hypertrophic
changes as is seen in GRMD skeletal muscle,[46] resulting in lower airway obstruction and
subsequent air trapping. Although striated muscle, rather than smooth muscle, is
characteristically described as being affected by dystrophin deficiency, dystrophin has been
identified in human airway smooth muscle.[47] Further, two dogs with German short-haired
pointer muscular dystrophy and radiographic evidence of hyperinflation were reported to
have abnormally increased expiratory efforts, consistent with obstructive lower airway
disease.[48]
The expected spirometric abnormality in people with obstructive lower airway disease
during forced exhalation is a decrease in peak expiratory flow, the opposite of the finding in
these GRMD dogs. However, increased tidal breathing peak expiratory flow has been
reported in horses with recurrent airway obstruction (heaves).[37,38] Horses in the study by
Petsche, et al. also showed increased ratios of expiratory flows compared with expiratory
flows later in expiration, as found in GRMD dogs.[37] Dogs with chronic bronchitis were
reported to have greater PTEF:EF25 compared with control dogs, also consistent with our
findings.[49] These differences in reported expiratory flows between animals and people
might be due to the measurement of maximal expiratory efforts in people and of tidal
breathing in dogs and horses. Purposeful, forced exhalation might obscure the relatively
smaller pressures generated by elastic recoil.
Increased time spent in expiration is another indication of obstructive airway disease.
Respiratory rate must be considered when comparing expiratory times between groups, so
ratios such as expiratory time to inspiratory time are used. In GRMD dogs the ratio of
expiratory time to inspiratory time was greater than that of control dogs. Although not
statistically significant, the P value was <0.1 for spirometric data. As such, a difference
might be found with a larger study population.
Other factors besides recoil can influence peak expiratory flow. Elevated respiratory rates in
dogs[50] and increased body size in people have been associated with increased expiratory
flows. Study dogs with GRMD had slightly lower respiratory rates compared with controls,
though the difference between groups based on spirometric data was not statistically
significant. While study dogs with GRMD were of lower body weight than control dogs,
body weight differences between these populations of dogs might not reflect thoracic
volume changes because of the influence of muscle atrophy on body weight. Regardless,
differences in peak tidal expiratory flow persisted when values were divided by body
weight.
The RIP bands and shirts might have decreased chest wall compliance, causing a restrictive
breathing pattern. However, care was taken during their application to avoid interference
with normal respiration. Although not directly comparable, a study by Rozanski, et al. failed
to find an effect of chest bandaging on functional residual capacity in dogs that were
standing or in sternal recumbency.[51] Most importantly, in our study, instrumentation of
dogs for RIP was identical between groups.
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Finally, an increase in peak expiratory flow can be found in tidal breathing spirometry in
dogs with restrictive disease.[52] With this said, the GRMD dogs failed to exhibit the
expected increased respiratory rates, decreased tidal volumes, or increased peak inspiratory
flows typical of restrictive disease. Further, although people with DMD are considered to
have a restrictive lung pattern of breathing, increased forced expiratory flows are not
reported in these patients. Surprisingly, GRMD dogs had a slower respiratory rate than
control dogs. Although this might reflect less anxiety due, potentially, to more frequent
handling of affected dogs, the heart rates of GRMD dogs were not slower than control dogs.
Importantly, as with other observations, data must be interpreted in the context of the mild
disease phenotype of the GRMD dogs studied. More severely affected dogs might have a
different pattern of disease.
An abnormal asynchronous breathing pattern, characterized by two expansions of the
abdomen for each expansion of the rib cage, was present in the majority of dogs with
GRMD. This pattern has been reported in some people with chronic obstructive pulmonary
disease (COPD), lending support to the possibility of airway obstruction and hyperinflation
contributing to respiratory dysfunction in these dogs.[53] This pattern was described by
Ashutosh, et al.[53] as the abdomen signal moving abruptly downward near or at the end of
inspiration and then moving upward later in expiration, with continued upward movement
during a variable part of the expiration.[53] An EMG of the diaphragm showed no activity
during expiration, indicating the second expansion of the abdomen was passive.[53] Further,
a few GRMD dogs demonstrated a greater degree of abnormal abdominal breathing with the
facemask off, which is more consistent with COPD than upper airway obstruction.
Hyperinflation resulting in displacement of the diaphragm and diaphragm fatigue have been
proposed as mechanisms contributing to paradoxical diaphragm movements in people with
COPD and emphysema.[53,54]
Lo Mauro, et al., did not report this double abdominal motion in people with DMD.[15]
Rather, they noted that the abdominal contribution to tidal volume progressively declined in
DMD patients. Our instrumentation did not allow accurate determination of the relative
percentage contributions of abdomen and rib cage to tidal volume. Preliminary results of
RIP of GRMD dogs from the same colony of dogs as those reported here demonstrated an
increase in phase angle in dogs with GRMD, indicating a loss of synchrony between peak
rib cage and peak abdominal motion.[55] Phase angles were normal in most GRMD dogs in
our study because the first abdominal deflection was relatively synchronous with that of the
rib cage, even though the second deflection was paradoxical. Explanations for differences in
results between these study populations include: age of dogs, with our dogs being older;
phenotypic variation with our dogs likely being less severely affected; and, that our dogs
were wearing facemasks at the time of RIP. Facemasks were used in our dogs because we
were not able to measure airflow by spirometry concurrently with RIP. For volume
calibration of RIP signals, tidal volume measured by spirometry was used. As breathing
through a mouthpiece is known to alter breathing patterns in people, we chose to perform
RIP with the mask in place for consistency with breathing during spirometry. Abnormal
abdominal motion was common to both studies and varied among affected dogs. This
finding suggests that RIP can be used to monitor disease progression over time. Additional
studies are needed to further substantiate these findings.
Evidence of hypoventilation was identified by arterial blood gas analysis, but not by tidal
breathing spirometry. Dogs with GRMD had higher PaCO2 and HCO3 concentrations
compared with control dogs. None of the dogs had a PaCO2 greater than 45 mmHg, the
maximum value of the reference range provided by the manufacturer. This absence of
absolute hypercapnia is consistent with findings in people with DMD, where daytime
elevations are not seen until terminal stages of disease.[3] The finding of increased PaCO2 in
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GRMD dogs is confounded by the difference in respiratory rates between GRMD dogs and
controls. Dogs with GRMD had a lower median respiratory rate during physical examination
than control dogs, which could contribute to an increase in PaCO2. However, there was no
statistical difference in minute volume or respiratory rates between groups as measured by
spirometry, and there was no statistical correlation between PaCO2 and respiratory rate
measured during physical examination or spirometry. The concurrent finding of increased
HCO3 in GRMD dogs could indicate a compensatory response to a more chronic increase in
PaCO2 that would not be influenced by respiratory rate. The best applications for arterial
blood gas analysis in GRMD might be for monitoring individual dogs, using their baseline
value as the control, or for assessment of pulmonary function in more advanced stages of the
disease.
Tidal breathing spirometry did not show evidence of hypoventilation or upper airway
obstruction in GRMD dogs, as hypothesized. Tidal breathing flow-volume loops in upper
airway obstruction of infants[56,57]and dogs[33-36,58] show characteristic flattening of the
inspiratory limb. Although the shape of the flow-volume loops from GRMD dogs was
consistent with upper airway obstruction, the expiration limb was consistently abnormal
rather than the inspiratory limb, when compared with the control dog population. The
abnormality in expiration was confirmed by the independent RIP results. Tidal breathing
spirometry is inherently less sensitive in detecting obstruction than studies performed with
forced breathing efforts. While dogs cannot be made to voluntarily expire maximally,
sensitivity of tidal breathing spirometry might be improved by inducing increased breathing
efforts. Exercise is not a ready solution because GRMD dogs are often reluctant to exert
themselves. Also, a lack of consistency in effort of exertion between dogs could confound
results. Systemic administration of doxapram, a respiratory stimulant, or inhalation of 10%
CO2 during spirometry, might improve sensitivity.[59] Further investigation is warranted.
In addition to potential confounding factors described above, there are other limitations to
this study. Importantly, the GRMD dogs of this study were mostly breeding males with an
overall mild disease phenotype. More severely affected GRMD dogs included in preclinical
studies might have more pronounced changes that could be tracked in response to treatment.
Serial monitoring of dogs, or testing of dogs with more severe disease, might have
uncovered additional abnormalities suitable for monitoring. Moreover, given the nature of
the study, we did not systematically collect additional phenotypic data with which to
correlate the respiratory dysfunction. Occult pneumonia in these dogs could have influenced
results, but would be an unlikely cause of increased peak expiratory flow. Control dogs were
carriers of GRMD and could have mild abnormalities.[24,60,61] Using these dogs as
controls had the benefit of using age-matched, and often litter-matched, dogs of the same
breed for comparison. A study by Amis, et al. found differences in tidal-breathing flow
volume loops in golden retriever dogs compared with other breeds.[33] Radiographic or
histologic evaluation of the lungs of the study dogs might have identified hyperinflation or
bronchial involvement. Unfortunately, we were limited to the reported procedures in this
study.
This study is the first to assess respiratory function of dogs with muscular dystrophy using
blood gas analysis, tidal breathing spirometry, and RIP, and compliments an earlier abstract
reporting results from RIP in dogs from this same colony.[55] The methods evaluated were
specifically chosen to avoid sedation, in anticipation of their use for repeated monitoring in
future studies, as sedation has the potential to affect measured results as well as influence
disease progression. The testing methods were successfully performed and provided specific
parameters for monitoring. However, the loss of data from even a few dogs is not ideal,
particularly when many treatment studies are limited to small subject numbers. Success of
data collection could be improved by having data analysis performed at the time of, or
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shortly after, collection. In our study, data were collected from all dogs prior to analysis,
after which the dogs were no longer available for repeated study. Initial training and
acclimatization of dogs to the procedures might also improve overall data quality. Such
training would be necessary for studies with repeated measures because dogs will become
acclimated through the repeat testing, and this change in degree of stress could influence
results. Spirometry, in particular, requires a compliant subject. Struggling against the mask
will result in leaking around the diaphragm and invalid results. Interestingly, the facemask
improved the quality of tracings from RIP. Decreased panting and body movement artifact
during RIP without a facemask in place could also be achieved by prolonged
instrumentation. Performance of RIP in dogs without a facemask is probably best done with
the dog alone in a kennel, in a quiet room. Such an approach is feasible through the
telemetric capabilities of the RIP system used. For both spirometry and RIP, identification of
more subtle abnormalities might be possible with greater numbers of analyzable breaths.
In summary, this study demonstrated the successful application of arterial blood gas
analysis, tidal breathing spirometry, and RIP for the monitoring of dogs with GRMD
without sedation. Further, we found that GRMD dogs have increased peak tidal expiratory
flows, which might be the result of hyperinflation, relative hypercapnia, and abnormal
abdominal breathing patterns. Additional study is warranted to investigate the underlying
pathophysiology of these findings.
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Tidal breathing flow-volumes (F-V) loops of 10 representative breaths from two control
dogs (A, B) and two GRMD dogs (C,D) displayed on graphs with identical scales. These
dogs were selected as representative of their groups based on peak tidal expiratory flows that
were closest to the median value for their group. The loops from GRMD dogs show visibly
greater expiratory flows (positive values) compared with inspiratory flows (negative values)
and compared with expiratory flows from control dogs.
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Example RIP tracings and Konno-Mead plots of 1 control dog and 3 GRMD dogs. The raw
output (volts) from the rib cage band (Vrc) and the adbomen band (Vab) are plotted against
time in the rectangular boxes, and against each other in the square (Konno-Mead) boxes.
The raw output was not calibrated or standardized. The control dog shows a synchronous
pattern with coordination between rib cage and abdominal motion and the Konno-Mead plot
has a positive slope. All control dogs and 3 GRMD dogs had similar patterns. GRMD Dogs
1-3 have two peaks of abdominal motion for each expansion of the rib cage. The first peak
occurs at or near peak expansion of the rib cage. The second occurs during expiration. The
size of the second abdominal peak is progressively larger compared with the first in these
dogs. In total, five GRMD dogs had a pattern similar to GRMD Dog 1. The Konno-Mead
plot shows a progressively deeper “C” shape in GRMD dogs 1 through 3. Tracings obtained
from GRMD Dogs 2 and 3 without a face mask in place show relatively greater abnormal
abdominal motion, with GRMD Dog 2 demonstrating complete paradoxical breathing.
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Table 1







RR (breaths/min) 26.7 (22.5/41.0) 20.7 (18.1/27.0) 0.064
TimeExp (sec) * 1.12 (0.77/1.38) 1.57 (1.20/1.88) 0.044
TimeInsp (sec) 1.10 (0.75/1.31) 1.30 (0.98/1.69) 0.098
TV (mL) 356 (216/492) 366 (309/421) 0.623
MV (mL) 9780 (8070/12780) 7310 (6880/8440) 0.140
PTEF (mL/sec) * 477 (373/691) 867 (573/1086) 0.002
PTIF (mL/sec) 445 (369/580) 400 (372/434) 0.651
TEF 50 (mL/sec) * 345 (317/621) 692 (518/765) 0.005
TIF 50 (mL/sec) 398 (335/522) 355 (324/392) 0.527
TEF 25 (mL/sec) 370 (284/467) 394 (359/471) 0.639
TEF 12.5 (mL/sec 273 (234/427) 207 (178/313) 0.207
Weight adjusted
TV/kg (mL/kg) 16.9 (9.8/24.0) 24.0 (18.5/26.8) 0.104
MV/kg (mL/kg) 486 (406/540) 466 (392/502) 0.910
PTEF/kg (mL/sec/kg) * 23.2 (20.1/28.4) 47.6 (37.4/68.0) <0.001
PTIF/kg (mL/sec/kg) 21.5 (17.0/25.3) 25.5 (20.6/26.4) 0.246
Ratios
Expiratory:Inspiratory
TimeExp:TimeInsp 1.07 (0.94/1.10) 1.24 (1.01/1.31) 0.090
PTEF:PTIF * 1.15 (1.00/1.16) 2.01 (1.53/2.48) <0.001
TEF50:TIF50 * 1.00 (0.91/1.17) 1.88 (1.72/2.30) 0.002
Inspiratory flows:earlier inspiratory flows
PTIF:TIF50 1.11 (1.09/1.14) 1.15 (1.10/1.19) 0.241
Expiratory flows:later expiratory flows
PTEF:TEF 50 1.19 (1.16/1.31) 1.21 (1.12/1.37) 0.970
PTEF:TEF 25 * 1.34 (1.23/1.56) 2.14 (1.67/2.50) 0.002
PTEF:TEF 12.5 * 1.69 (1.46/2.15) 4.22 (3.07/5.07) <0.001
TEF 50:TEF 25 * 1.10 (1.05/1.27) 1.72 (1.44/1.98) <0.001
TEF 50:TEF 12.5 * 1.43 (1.26/1.65) 3.17 (2.11/3.67) <0.001
TEF2 5:TEF 12.5 * 1.25 (1.20/1.29) 1.86 (1.51/2.99) 0.002
GRMD, golden retriever muscular dystrophy; RR, respiratory rate; TimeExp, expiratory time; TimeInsp, inspiratory time; TV, tidal volume; MV,
minute volume; PTEF, peak tidal expiratory flow; PTIF, peak tidal inspiratory flow; TEF50, tidal expiratory flow at 50% of TV; TIF50, tidal
inspiratory flow at 50% of TV; TEF25, tidal expiratory flow at 25% of TV; TEF12.5, tidal expiratory flow at 12.5% of TV;
*
statistically significant difference between groups.
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Table 2
Results of respiratory inductance plethysmography from 8 dogs with GRMD and 9 control carrier dogs






RR (breaths/min) 31.3 (25.3/44.5) 26.9 (18.8/41.2) 0.482
TimeExp (sec) 0.95 (0.70/1.26) 1.29 (0.93/2.24) 0.139
TimeInsp (sec) 0.99 (0.72/1.16) 1.03 (0.74/1.30) 0.590
TV (mL) 318 (218/501) 309 (272/421) 0.896
MV (mL) 9771 (7183/13273) 8871 (6273/14110) 0.140
PTEF (mL/sec) * 644 (525/981) 1257 (1077/1541) 0.008
PTIF (mL/sec) 514 (445/842) 709 (412/845) 0.757
TEF50 (mL/sec) * 526 (441/655) 1201 (1003/1411) <0.001
TIF 50 (mL/sec) 421 (349/630) 525 (366/687) 0.792
Phase (degrees) 9.7 (−0.2/12.1) 3.7 (−6.3/4.2) 0.194
Ratios
Expiratory:Inspiratory
TimeExp:TimeInsp 1.10 (0.94/1.14) 1.43 (1.01/1.81) 0.112
PTEF:PTIF * 1.26 (1.13/1.35) 1.82 (1.46/2.65) 0.004
TEF50:TIF50 * 1.28 (1.03/1.36) 2.03 (1.91/2.81) <0.001
GRMD, golden retriever muscular dystrophy; RR, respiratory rate; TimeExp, expiratory time; TimeInsp, inspiratory time; TV, tidal volume; MV,
minute volume; PTEF, peak tidal expiratory flow; PTIF, peak tidal inspiratory flow; TEF50, tidal expiratory flow at 50% of TV; TIF50, tidal
inspiratory flow at 50% of TV;
*
statistically significant difference between groups.
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